Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University / Corinne Linardic, MD/PhD |
Innovation Grants |
2019 |
North Carolina |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease |
St. Jude Children's Research Hospital / Linda Hendershot, PhD |
Innovation Grants |
2019 |
Tennessee |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia |
Children's Hospital of Philadelphia / Wei Tong, PhD |
Innovation Grants |
2019 |
Pennsylvania |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome |
Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD |
Epidemiology Grants |
2019 |
Pennsylvania |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |